Search
for
Sort by
Research 121–150 of 1000+
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Dermatology of androgen-related disorders
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Postmenopausal hyperandrogenism
- Polycystic ovary syndrome and mental health: a call to action
- Herbs as Antiandrogenic Agents
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Insulin Resistance and Polycystic Ovary Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome
- Hirsutism causes and treatments.
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- SUN-106 Nonsurgical Management of Hyperandrogenism in a Postmenopausal Woman
- A review of hyperandrogenism state in polycystic ovarian syndrome
- Hiperandrogenismo femenino
- Behandlung mit Antiandrogenen in der Gynäkologie
- G4, is a new transgenic mouse model for the polycystic ovaries syndrome
- The pathophysiology of polycystic ovary syndrome
- Contemporary medical therapy for polycystic ovary syndrome
- Hormone therapy in acne
- Diagnosing polycystic ovary syndrome
- Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report
- Choice of treatment for women with polycystic ovary syndrome
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- PCOS-Management of Androgenetic Alopecia
- Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
- The Dutasteride: Miraculous Drug in Alopecia Treatment A Review
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess